Why Hims & Hers Health Stock Is Rising Today
Why Hims & Hers Health Stock Is Rising Today
Hims and Hers Health Inc. (NYSE:HIMS) shares are up Tuesday after the company reported better-than-expected first quarter financial results.
Hims and Hers Health Inc.（紐約證券交易所代碼：HIMS）週二股價上漲，此前該公司公佈的第一季度財務業績好於預期。
The Details: After the market close on Monday, Hims & Hers Health reported strong first-quarter results that included revenue of $278.2 million, representing a 46% increase from $190.8 million in the first quarter of 2023. The number beat analyst estimates of $270.382 million.
詳情：週一收盤後，Hims & Hers Health公佈了強勁的第一季度業績，其中包括2.782億美元的收入，較2023年第一季度的1.908億美元增長了46％。這個數字超過了分析師估計的2.70382億美元。
The company posted net income of $11.1 million and EPS of 5 cents, beating EPS estimates of 2 cents by 150%.
該公司公佈的淨收入爲1,110萬美元，每股收益爲5美分，比預期的每股收益2美分高出150％。
In addition, Hims & Hers Health reported adjusted EBITDA of $32.3 million for the first quarter compared to $6.1 million in the first quarter of 2023.
此外，Hims & Hers Health報告稱，第一季度調整後的息稅折舊攤銷前利潤爲3,230萬美元，而2023年第一季度爲610萬美元。
"The business continues to generate robust performance across our operations as we execute on our mission to make the world feel great through the power of better health," said Yemi Okupe, CFO of Hims & Hers Health.
Hims & Hers Health首席財務官Yemi Okupe表示：“在我們履行使命的同時，通過改善健康的力量讓世界感覺良好，該業務繼續在運營中取得強勁的業績。”
The company saw 41% year-over-year growth in subscribers during the quarter, bringing total subscribers up to 1.7 million.
該公司的訂戶在本季度同比增長了41％，使訂戶總數達到170萬。
Hims & Hers Health also issued guidance for the second quarter. The company expects revenue of $292 million to $297 million versus estimates of $288.073 million. Hims & Hers Health also sees adjusted EBITDA between $30 million and $35 million.
Hims & Hers Health還發布了第二季度的指導方針。該公司預計收入爲2.92億美元至2.97億美元，而預期爲2.88073億美元。Hims & Hers Health還預計，調整後的息稅折舊攤銷前利潤在3000萬至3500萬美元之間。
For the full fiscal year, the company expects revenue of $1.20 billion to $1.23 billion versus estimates of $1.191 billion.
該公司預計整個財年的收入爲12.0億美元至12.3億美元，而預期爲11.91億美元。
Related Link: 12 Health Care Stocks Moving in Monday's After-Market Session.
相關鏈接：週一盤後交易時段，12只醫療保健類股票走勢。
On Tuesday, Piper Sandler maintained a Neutral rating on the stock and raised the price target from $11 to $13. Deutsche Bank also maintained Hims & Hers Health with a Hold rating and raised the price target from $14 to $16.
週二，派珀·桑德勒維持該股的中性評級，並將目標股價從11美元上調至13美元。德意志銀行還將Hims & Hers的健康維持在持有評級，並將目標股價從14美元上調至16美元。
Price Action: According to Benzinga Pro, Hims & Hers Health shares were up 7.25% at $12.48 at the time of publication.
價格走勢：根據Benzinga Pro的數據，Hims & Hers Health的股價在發佈時上漲7.25％，至12.48美元。
Image: Courtesy of Hims & Hers Health, Inc.
圖片：由 Hims & Hers Health, Inc. 提供
譯文內容由第三人軟體翻譯。